These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 21618200)
1. A possible role of leptin-associated increase in soluble interleukin-2 receptor diminishing a clinical response to infliximab in rheumatoid arthritis: Comment on the article by Klaasen et al. Shin JI; Park SJ; Kim JH Arthritis Rheum; 2011 Sep; 63(9):2833-4; author reply 2834. PubMed ID: 21618200 [No Abstract] [Full Text] [Related]
2. Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al. Pincus T; Yazici Y; Yazici H; Kavanaugh AF; Kremer JM; Wolfe F Arthritis Rheum; 2005 Dec; 52(12):4044-5; author reply 4045-7. PubMed ID: 16320353 [No Abstract] [Full Text] [Related]
3. Comparison between adalimumab, etanercept, and infliximab in rheumatoid arthritis: comment on the article by Hetland et al. Francis S; Block MJ Arthritis Rheum; 2010 Sep; 62(9):2826; author reply 2826-8. PubMed ID: 20556822 [No Abstract] [Full Text] [Related]
4. Body mass index and clinical response to infliximab in rheumatoid arthritis. Klaasen R; Wijbrandts CA; Gerlag DM; Tak PP Arthritis Rheum; 2011 Feb; 63(2):359-64. PubMed ID: 21279992 [TBL] [Abstract][Full Text] [Related]
5. Effect of golimumab combined with methotrexate on radiographic progression in rheumatoid arthritis: comment on the article by Emery et al. Graudal N; Jürgens G Arthritis Rheum; 2012 Apr; 64(4):1297-8; author reply 1298-9. PubMed ID: 22231914 [No Abstract] [Full Text] [Related]
6. Comment on "Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks" by Yokoe et al. Nagashima T; Okazaki H; Kamata Y; Minota S Mod Rheumatol; 2012 Aug; 22(4):638-9; authoe reply 640-2. PubMed ID: 22669601 [No Abstract] [Full Text] [Related]
7. Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'. Gonzalez-Gay MA; Gonzalez-Juanatey C; Miranda-Filloy JA; Martin J; Garcia-Unzueta MT; Llorca J Arthritis Res Ther; 2011 Apr; 13(2):404. PubMed ID: 21542887 [No Abstract] [Full Text] [Related]
9. Reconstitution of B cells after B cell-depletion therapy: Comment on the article by Leandro et al. Teng YK; van Tilborg A; van Laar JM Arthritis Rheum; 2006 Sep; 54(9):3062-3; author reply 3063. PubMed ID: 16948141 [No Abstract] [Full Text] [Related]
10. Infliximab treatment of rheumatoid arthritis. Maini SR Rheum Dis Clin North Am; 2004 May; 30(2):329-47, vii. PubMed ID: 15172044 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis. Cobo Ibáñez T; Yehia Tayel M; Balsa Criado A; Hernández Sanz A; Martín Mola E Rheumatology (Oxford); 2005 Nov; 44(11):1467-8. PubMed ID: 16174647 [No Abstract] [Full Text] [Related]
12. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis. van den Bemt BJ; Vos K; den Broeder AA; Blom M; Thurlings RM; Bartelds GM; Stapel SO; Barrera P; Tak PP; Nurmohamed MT; Wolbink GJ Ann Rheum Dis; 2009 Aug; 68(8):1368-9. PubMed ID: 19605744 [No Abstract] [Full Text] [Related]
13. Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis. Bargagli E; Galeazzi M; Rottoli P Eur Respir J; 2004 Oct; 24(4):708. PubMed ID: 15459153 [No Abstract] [Full Text] [Related]
14. In early rheumatoid arthritis the combination of methotrexate and infliximab over 2 years reduces the progression of radiological lesions more than methotrexate alone. Montecucco C Clin Exp Rheumatol; 2005; 23(3):289-291. PubMed ID: 15971414 [No Abstract] [Full Text] [Related]
15. Association between the FCGR3A V158F polymorphism and the clinical response to infliximab in rheumatoid arthritis and spondyloarthritis patients. Morales-Lara MJ; Conesa-Zamora P; García-Simón MS; Pedrero F; Santaclara V; Perez-Guillermo M; Soriano-Navarro E Scand J Rheumatol; 2010 Nov; 39(6):518-20. PubMed ID: 20560817 [No Abstract] [Full Text] [Related]
16. Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks. Yokoe I; Nishio S; Sato H; Kobayashi H Mod Rheumatol; 2011 Dec; 21(6):710-4. PubMed ID: 21656090 [No Abstract] [Full Text] [Related]
17. Improved response to infliximab after leukocytapheresis in a patent with rheumatoid arthritis. Azuma T; Ishimaru H; Hatta K; Kori Y Mod Rheumatol; 2007; 17(3):253-5. PubMed ID: 17564785 [TBL] [Abstract][Full Text] [Related]
18. Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab. Kuuliala A; Nissinen R; Kautiainen H; Repo H; Leirisalo-Repo M Ann Rheum Dis; 2006 Jan; 65(1):26-9. PubMed ID: 15941839 [TBL] [Abstract][Full Text] [Related]
19. Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis. Hammoudeh M Rheumatology (Oxford); 2006 Mar; 45(3):357-9. PubMed ID: 16368727 [No Abstract] [Full Text] [Related]